Section 240.009 - Advisory BoardThe Department shall establish an advisory board, comprised of representatives of the medical, insurance, and consumer communities, to advise the Department on matters pertaining to bone marrow transplants for breast cancer patients. Such advisory board shall meet as of tenas necessary, but no less than three times a year, in accordance with procedures established by the Department. The advisory board shall advise the Department as to the following:
(A) the desirability, based upon current research and medical data, of amending the eligibility criteria for bone marrow transplants for breast cancer patients established in 105 CMR 240.000. In particular, the advisory board shall advise the Department as to whether there is evidence that bone marrow transplants for a particular stage of cancer not covered by 105 CMR 240.000 shows promise of being a useful treatment for that stage and is likely to be at least as effective as conventional treatment;(B) the desirability of amending the list developed by the Department of impartial and independent review boards;(C) the appropriateness of amending the criteria for suitable sites for bone marrow transplantation established in 105 CMR 240.006; and(D) any matter affecting the implementation of St. 1993, c. 458 or 105 CMR 240.000.